Our clinical grade LaNeo™ MDMA product

PharmAla Biotech is the only company currently sourcing finished, clinical grade LaNeo™ MDMA Drug Product in North America. PharmAla’s drug API is  encapsulated under GMP conditions, and is available to entities who have Controlled Substances licenses, Section 56 Ministerial Exemptions, or Clinical Trial numbers within Canada. Drug Product can also be exported for use by clinical trial practitioners globally, subject to the issuance of import and export permit.


Interested in discussing acquisition of Drug Product for the purposes of clinical research?

Example: 555-555-1234

Please provide any available further information, including required dosage, protocol information, and required timeline for delivery.